<DOC>
	<DOCNO>NCT00321152</DOCNO>
	<brief_summary>The purpose study test whether oral 6 ( S ) -5-MTHF ( DeplinÂ® ) safe effective relieve depression add standard kind antidepressant call serotonin reuptake inhibitor ( SSRIs ) .</brief_summary>
	<brief_title>A Study 6 ( S ) -5-MTHF Among Serotonin Reuptake Inhibitor ( SSRI ) -Resistant Outpatients With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description>The study consist two sequential phase , last total four week ( 8 week total ) , visit every 10 day . Once patient agree participate study sign informed consent document , full medical psychiatric history take physical examination blood draw perform . Screen rating scale perform . Screened eligible patient ask return two week later baseline visit randomize double-blind treatment placebo Deplin ( 6 ( S ) -5-MTHF ) . The double-blind treatment last 60 day , patient see every 10 day . Subjects randomize one three treatment group : ) Deplin/Deplin , b ) placebo/Deplin , c ) placebo/placebo . Patients great 50 % chance receive active medication ( Deplin ) point 8 week study - For patient randomly assign Deplin/Deplin sequence , dose 6 ( S ) -5-MTHF 7.5 mg/day first phase study , 15 mg/d second phase study . - For patient randomly assign placebo/Deplin sequence , dose 6 ( S ) -5-MTHF 7.5 mg/day second phase study . - For patient randomly assign placebo/placebo sequence , tablet study medication placebo phase study . All patient ask take two tablet blind study medication morning , addition stable dose ongoing SSRI treatment . Each study medication tablet either 7.5 mg 6 ( S ) -5-MTHF match placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>1865 year old Meet criterion current Major Depressive Disorder Currently take SSRI Pregnant woman Unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurological , hematological disease . Prior course MTHF augmentation , intolerance MTHF dose substance use disorder active within last six month , bipolar disorder ( current past ) , psychotic disorder ( current past ) . Have fail 2 adequate antidepressant trial current Major Depressive Episode .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>